17:49 , Mar 23, 2018 |  BC Week In Review  |  Financial News

Neuromuscular play NMD raises EUR38M in series A

NMD Pharma ApS (Aarhus, Denmark) raised €38 million ($46.6 million) in a tranched series A round led by new investor INKEF on March 22. Fellow new investor Roche Venture Fund and existing investors Novo Seeds...
20:49 , Mar 22, 2018 |  BC Extra  |  Financial News

NMD raises €38M series A

NMD Pharma ApS (Aarhus, Denmark) raised €38 million ($46.6 million) in a tranched series A round led by new investor INKEF. Fellow new investor Roche Venture Fund and existing investors Novo Seeds and Lundbeckfonden Emerge...
20:32 , Mar 22, 2018 |  BioCentury  |  Finance

NMD treats A to Z

The broad applicability of NMD Pharma ApS’s approach to treating neuromuscular conditions persuaded INKEF Capital to lead the company’s tranched €38 million ($46.6 million) series A round. Fellow new investor Roche Venture Fund and existing...
21:40 , Jan 3, 2018 |  BC Innovations  |  Product R&D

Expanding small molecule horizons

With a platform boasting more than a decade of preclinical rigor and $55.3 million in series A funding, Expansion Therapeutics Inc. is the latest company to step into the RNA-binding small molecule arena. The newco...